Potential role of propolis in wound healing: Biological properties and therapeutic activities

Biomedicine and Pharmacotherapy

Volumn 98, Issue , 2018, Pages 469-483

  Oryan, Ahmad ^a   Alemzadeh, Esmat ^a   Moshiri, Ali ^b  

^a SHIRAZ UNIVERSITY   (Iran)

^b Dr Moshiri Veterinary Clinic   (Iran)

Author keywords

Anti inflammatory; Anti oxidant; Antimicrobial; Meta analysis; Propolis; Wound healing

Indexed keywords

PROPOLIS; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; CHEMICAL COMPOSITION; CLINICAL TRIAL (TOPIC); CONTACT DERMATITIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SAFETY; HISTORY OF MEDICINE; HUMAN; IN VIVO STUDY; MAST CELL; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; WOUND HEALING; ANIMAL; DRUG EFFECT;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL PRODUCTS; HUMANS; PROPOLIS; WOUND HEALING;

EID: 85039157798     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.12.069     Document Type: Review

References (154)

1. Eyng, C., Murakami, A., Santos, T., Silveira, T., Pedroso, R., Lourenço, D., Immune responses in broiler chicks fed propolis extraction residue-supplemented diets. Asian-Australas. J. Anim. Sci., 28(1), 2015, 135.
2. Xuan, H., Li, Z., Yan, H., Sang, Q., Wang, K., He, Q., et al. Antitumor activity of Chinese propolis in human breast cancer MCF-7 and MDA-MB-231 cells. Evid. Based Complement. Altern. Med., 2014, 2014.
3. Datiashvili, R.O., Yueh, J.H., Management of complicated wounds of the extremities with scapular fascial free flaps. J. Reconstr. Microsurg. 28:08 (2012), 521–528.
4. Hasan, M.Y., Teo, R., Nather, A., Negative-pressure wound therapy for management of diabetic foot wounds: a review of the mechanism of action, clinical applications, and recent developments. Diabet. Foot Ankle, 6, 2015, 27618.
5. Oryan, A., Mohammadalipour, A., Moshiri, A., Tabandeh, M.R., Topical application of Aloe vera accelerated wound healing, modeling, and remodeling. Ann. Plast. Surg. 77:1 (2016), 37–46.
6. Oryan, A., Moshiri, A., Meimandi-Parizi, A., In vitro characterization of a novel tissue engineered based hybridized nano and micro structured collagen implant and its in vivo role on tenoinduction, tenoconduction, tenogenesis and tenointegration. J. Mater. Sci. Mater. Med. 25:3 (2014), 873–897.
7. Bosio, K., Avanzini, C., D'avolio, A., Ozino, O., Savoia, D., In vitro activity of propolis against Streptococcus pyogenes. Lett. Appl. Microbiol. 31:2 (2000), 174–177.
8. Kuropatnicki, A.K., Szliszka, E., Krol, W., Historical aspects of propolis research in modern times. Evid. Based Complement. Altern. Med., 2013, 2013.
9. Yaghoubi, M., Gh, G., Satari, R., Antimicrobial activity of Iranian propolis and its chemical composition. DARU 15:1 (2007), 45–48.
10. Gavanji, S., Larki, B., Comparative effect of propolis of honey bee and some herbal extracts on Candida Albicans. Chin. J. Integr. Med., 2015, 1–7.
11. Bezerra, A.M.F., Bezerra, K.K.S., Albuquerque, F.G.F., Fernandes Filho, A., Casimiro, G.S., Nunes, E.M., et al. Red propolis antifungal action on species of Candida of the oral cavity. Int. Arch. Med., 8, 2015.
12. Cushnie, T.T., Lamb, A.J., Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 26:5 (2005), 343–356.
13. Qiao, Z., Chen, R., Isolation and identification of antibiotic constituents of propolis from Henan. Zhongguo Zhong Yao Za Zhi, 16(8), 1991, 481 in Chinese.
14. Wojtyczka, R.D., Dziedzic, A., Idzik, D., Kępa, M., Kubina, R., Kabała-Dzik, A., et al. Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs. Molecules 18:8 (2013), 9623–9640.
15. Jastrzębska-Stojko, Ż., Stojko, R., Rzepecka-Stojko, A., Kabała-Dzik, A., Stojko, J., Biological activity of propolis-honey balm in the treatment of experimentally-evoked burn wounds. Molecules 18:11 (2013), 14397–14413.
16. Hoşnuter, M., Gürel, A., Babucçu, O., Armutcu, F., Kargi, E., Işikdemir, A., The effect of CAPE on lipid peroxidation and nitric oxide levels in the plasma of rats following thermal injury. Burns 30:2 (2004), 121–125.
17. Valenzuela-Barra, G., Castro, C., Figueroa, C., Barriga, A., Silva, X., de las Heras, B., et al. Anti-inflammatory activity and phenolic profile of propolis from two locations in Región Metropolitana de Santiago, Chile. J. Ethnopharmacol. 168 (2015), 37–44.
18. Gregory, S.R., Piccolo, N., Piccolo, M.T., Piccolo, M.S., Heggers, J.P., Comparison of propolis skin cream to silver sulfadiazine: a naturopathic alternative to antibiotics in treatment of minor burns. J. Altern. Complement. Med. 8:1 (2002), 77–83.
19. Kurek-Górecka, A., Rzepecka-Stojko, A., Górecki, M., Stojko, J., Sosada, M., Świerczek-Zięba, G., Structure and antioxidant activity of polyphenols derived from propolis. Molecules 19:1 (2013), 78–101.
20. Pessolato, A.G.T., dos Santos Martins, D., Ambrósio, C.E., Mançanares, C.A.F., de Carvalho, A.F., Propolis and amnion reepithelialise second-degree burns in rats. Burns 37:7 (2011), 1192–1201.
21. Olczyk, P., Komosinska-Vassev, K., Winsz-Szczotka, K., Stojko, J., Klimek, K., Kozma, E.M., Propolis induces chondroitin/dermatan sulphate and hyaluronic acid accumulation in the skin of burned wound. Evid. Based Complement. Altern. Med., 2013, 2013.
22. Wagh, V.D., Propolis: a wonder bees product and its pharmacological potentials. Adv. Pharmacol. Sci., 2013, 2013.
23. Castaldo, S., Capasso, F., Propolis, an old remedy used in modern medicine. Fitoterapia 73 (2002), S1–S6.
24. Najafi, M.F., Vahedy, F., Seyyedin, M., Jomehzadeh, H.R., Bozary, K., Effect of the water extracts of propolis on stimulation and inhibition of different cells. Cytotechnology 54:1 (2007), 49–56.
25. Burdock, G., Review of the biological properties and toxicity of bee propolis (propolis). Food Chem. Toxicol. 36:4 (1998), 347–363.
26. Huang, S., Zhang, C.-P., Wang, K., Li, G.Q., Hu, F.-L., Recent advances in the chemical composition of propolis. Molecules 19:12 (2014), 19610–19632.
27. Orhan, H., Marol, S., Hepşen, İ.F., Şahin, G., Effects of some probable antioxidants on selenite-induced cataract formation and oxidative stress-related parameters in rats. Toxicology 139:3 (1999), 219–232.
28. Toreti, V.C., Sato, H.H., Pastore, G.M., Park, Y.K., Recent progress of propolis for its biological and chemical compositions and its botanical origin. Evid. Based Complement. Altern. Med., 2013, 2013.
29. Silva-Carvalho, R., Baltazar, F., Almeida-Aguiar, C., Propolis: a complex natural product with a plethora of biological activities that can be explored for drug development. Evid. Based Complemen. Altern. Med., 2015, 2015.
30. Banskota, A.H., Tezuka, Y., Kadota, S., Recent progress in pharmacological research of propolis. Phytother. Res. 15:7 (2001), 561–571.
31. Daleprane, J.B., Abdalla, D.S., Emerging roles of propolis: antioxidant, cardioprotective, and antiangiogenic actions. Evid. Based Complement. Altern. Med., 2013, 2013.
32. Kosalec, I., Sankovic, K., Zovko, M., Orsolic, N., Bakmaz, M., Kalogjera, Z., et al. Antimicrobial and antioxidant activity of propolis from Croatia and Brazil: a comparative study. Planta Med., 73(09), 2007, 165.
33. Miguel, M.G., Antunes, M.D., Is propolis safe as an alternative medicine?. J. Pharm. Bioallied Sci., 3(4), 2011, 479.
34. Shimizu, T., Hino, A., Tsutsumi, A., Park, Y.K., Watanabe, W., Kurokawa, M., Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice. Antivir. Chem. Chemother. 19:1 (2008), 7–13.
35. Bankova, V.S., Christov, R., Tejera, A.D., Lignans and other constituents of propolis from the Canary Islands. Phytochemistry 49:5 (1998), 1411–1415.
36. Christov, R., Bankova, V., Tsvetkova, I., Kujumgiev, A., Tejera, A.D., Antibacterial furofuran lignans from Canary Islands propolis. Fitoterapia 70:1 (1999), 89–92.
37. Daleprane, J.B., da Silva Freitas, V., Pacheco, A., Rudnicki, M., Faine, L.A., Doerr, F.A., et al. Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis. J. Nutr. Biochem. 23:6 (2012), 557–566.
38. Montenegro, G., Peña, R., Avila, G., Timmermann, B., Botanical origin and seasonal production of propolis in hives of Central Chile. 2001, Boletim de Botânica da Universidade de São Paulo, 1–6.
39. Muñoz, O., Peña, R.C., Ureta, E., Montenegro, G., Caldwell, C., Timmermann, B.N., Phenolic compounds of propolis from central Chilean matorral. Z. Naturforsch. C 56:3–4 (2001), 273–277.
40. Russo, A., Longo, R., Vanella, A., Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia 73 (2002), S21–S29.
41. Bankova, V., Recent trends and important developments in propolis research. Evid. Based Complement. Altern. Med. 2:1 (2005), 29–32.
42. Hegazi, A.G., El Hady, F.K.A., Egyptian propolis: 3. Antioxidant, antimicrobial activities and chemical composition of propolis from reclaimed lands. Z. Naturforsch. C 57:3–4 (2002), 395–402.
43. Miguel, M.G., Chemical and biological properties of propolis from the western countries of the Mediterranean basin and Portugal. Int. J. Pharm. Pharm. Sci., 3(5), 2013.
44. Darwish, R.M., Ra'ed, J., Zarga, M.H.A., Nazer, I.K., Antibacterial effect of Jordanian propolis and isolated flavonoids against human pathogenic bacteria. Afr. J. Biotechnol., 9(36), 2011.
45. Shaheen, S.A., Zarga, M.H.A., Nazer, I.K., Darwish, R.M., Al-Jaber, H.I., Chemical constituents of Jordanian propolis. Nat. Prod. Res. 25:14 (2011), 1312–1318.
46. Petrova, A., Popova, M., Kuzmanova, C., Tsvetkova, I., Naydenski, H., Muli, E., et al. New biologically active compounds from Kenyan propolis. Fitoterapia 81:6 (2010), 509–514.
47. Búrquez, Md.J.G., Mosqueda, Md.L.J., Mendoza, H.R., Zárate, C.I.S., Miranda, L.C., Sánchez, T.A.C., Protective effect of a mexican propolis on MDBK cells exposed to Aujeszky's disease virus (Pseudorabies virus). Afr. Tradit. Complement. Altern. Med. 12:4 (2015), 106–111.
48. Martinotti, S., E. Propolis: a new frontier for wound healing?. Burns Trauma, 3(1), 2015, 1.
49. Inui, S., Hosoya, T., Shimamura, Y., Masuda, S., Ogawa, T., Kobayashi, H., et al. Solophenols B–D and Solomonin: new prenylated polyphenols isolated from propolis collected from the Solomon Islands and their antibacterial activity. J. Agric. Food Chem. 60:47 (2012), 11765–11770.
50. Czyżewska, U., Konończuk, J., Teul, J., Drągowski, P., Pawlak-Morka, R., Surażyński, A., et al. Verification of chemical composition of commercially available propolis extracts by gas chromatography–mass spectrometry analysis. J. Med. Food 18:5 (2015), 584–591.
51. Uzel, A., Önçağ Ö., Çoğulu, D., Gençay, Ö., Chemical compositions and antimicrobial activities of four different Anatolian propolis samples. Microbiol. Res. 160:2 (2005), 189–195.
52. Berretta, A.A., Nascimento, A.P., Pires Bueno, P.C., Lima Leite Vaz, M.Md.O., Marchetti, J.M., Propolis standardized extract (EPP-AF (R)), an innovative chemically and biologically reproducible pharmaceutical compound for treating wounds. Int. J. Biol. Sci., 2012, 512–521.
53. Chikaraishi, Y., Izuta, H., Shimazawa, M., Mishima, S., Hara, H., Angiostatic effects of Brazilian green propolis and its chemical constituents. Mol. Nutr. Food Res. 54:4 (2010), 566–575.
54. Moura, S.A.Ld., Negri, G., Salatino, A., Lima, L.Dd.C., Dourado, L.P.A., Mendes, J.B., et al. Aqueous extract of Brazilian green propolis: primary components, evaluation of inflammation and wound healing by using subcutaneous implanted sponges. Evid. Based Complement. Altern. Med., 2011, 2011.
55. Hu, F., Hepburn, H., Li, Y., Chen, M., Radloff, S., Daya, S., Effects of ethanol and water extracts of propolis (bee glue) on acute inflammatory animal models. J. Ethnopharmacol. 100:3 (2005), 276–283.
56. Paulino, N., Abreu, S.R.L., Uto, Y., Koyama, D., Nagasawa, H., Hori, H., et al. Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis. Eur. J. Pharmacol. 587:1 (2008), 296–301.
57. Rufatto, L.C., Dos Santos, D.A., Marinho, F., Henriques, J.A.P., Ely, M.R., Moura, S., Red propolis: chemical composition and pharmacological activity. Asian Pac. J. Trop. Biomed. 7:7 (2017), 591–598.
58. Daugsch, A., Moraes, C.S., Fort, P., Park, Y.K., Brazilian red propolis—chemical composition and botanical origin. Evid. Based Complement. Altern. Med. 5:4 (2008), 435–441.
59. Donnelly, D.M., Keenan, P., Prendergast, J., Isoflavonoids of Dalbergia ecastophyllum. Phytochemistry 12:5 (1973), 1157–1161.
60. Batista, L.L.V., Campesatto, E.A., Assis, M.L.Bd., Barbosa, A.P.F., Grillo, L.A.M., Dornelas, C.B., Comparative study of topical green and red propolis in the repair of wounds induced in rats. Rev. Col. Bras. Cir. 39:6 (2012), 515–520.
61. de Almeida, E.B., Cardoso, J.C., de Lima, A.K., de Oliveira, N.L., de Pontes-Filho, N.T., Lima, S.O., et al. The incorporation of Brazilian propolis into collagen-based dressing films improves dermal burn healing. J. Ethnopharmacol. 147:2 (2013), 419–425.
62. Ahn, M.-R., Kumazawa, S., Usui, Y., Nakamura, J., Matsuka, M., Zhu, F., et al. Antioxidant activity and constituents of propolis collected in various areas of China. Food Chem. 101:4 (2007), 1383–1392.
63. Chen, C.-N., Wu, C.-L., Shy, H.-S., Lin, J.-K., Cytotoxic prenylflavanones from Taiwanese propolis. J. Nat. Prod. 66:4 (2003), 503–506.
64. Hegazi, A.G., El Hady, F.K.A., Egyptian propolis: 3. Antioxidant, antimicrobial activities and chemical composition of propolis from reclaimed lands. Zeitschrift Für Naturforschung C 57:3–4 (2002), 395–402.
65. de Groot, A.C., Propolis: a review of properties, applications, chemical composition, contact allergy, and other adverse effects. Dermatitis 24:6 (2013), 263–282.
66. Shokri, H., Katiraee, F., Fatahinia, M., Minooeianhaghighi, M.H., Chemical composition and antifungal potential of Iranian propolis against Candida krusei strains. J. Apic. Res. 56:5 (2017), 581–587.
67. Ristivojević P., Trifković J., Andrić F., Milojković-Opsenica, D., Poplar-type propolis: chemical composition, botanical origin and biological activity. Nat. Prod. Commun. 10:11 (2015), 1869–1876.
68. Mesquita, Rd.C.G., Franciscon, C.H., Flower visitors of Clusia nemorosa GFW Meyer (Clusiaceae) in an Amazonian white-sand campina. Biotropica, 1995, 254–258.
69. Tomás-Barberán, F.A., García-Viguera, C., Vit-Olivier, P., Ferreres, F., Tomás-Lorente, F., Phytochemical evidence for the botanical origin of tropical propolis from Venezuela. Phytochemistry 34:1 (1993), 191–196.
70. Christov, R., Bankova, V., Hegazi, A., Hady, F., Popov, S., Chemical composition of Egyptian propolis. Zeitschrift Für Naturforschung 53C:3–4 (1998), 197–200.
71. El Hady, F.K.A., Hegazi, A.G., Egyptian propolis: 2. Chemical composition, antiviral and antimicrobial activities of East Nile Delta propolis. Zeitschrift Für Naturforschung C 57:3–4 (2002), 386–394.
72. Popova, M., Trusheva, B., Antonova, D., Cutajar, S., Mifsud, D., Farrugia, C., et al. The specific chemical profile of Mediterranean propolis from Malta. Food Chem. 126:3 (2011), 1431–1435.
73. Montenegro, G., Mujica, A., Peña, R., Gómez, M., Serey, I., Timmermann, B., Similitude pattern and botanical origin of the Chilean propolis. Phyton. 53 (2004), 145–153.
74. Trusheva, B., Popova, M., Bankova, V., Simova, S., Marcucci, M.C., Miorin, P.L., et al. Bioactive constituents of Brazilian red propolis. Evid. Based Complement. Altern. Med. 3:2 (2006), 249–254.
75. Park, Y.K., Alencar, S.M., Aguiar, C.L., Botanical origin and chemical composition of Brazilian propolis. Agric. Food Chem. 50:9 (2002), 2502–2506.
76. Shouqin, Z., Jun, X., Changzheng, W., High hydrostatic pressure extraction of flavonoids from propolis. J. Chem. Technol. Biotechnol. 80:1 (2005), 50–54.
77. Barud, Hd.S., de Araújo Júnior, A.M., Saska, S., Mestieri, L.B., Campos, J.A.D.B., De Freitas, R.M., et al. Antimicrobial Brazilian propolis (EPP-AF) containing biocellulose membranes as promising biomaterial for skin wound healing. Evid. Based Complement. Altern. Med., 2013, 2013.
78. Heilborn, J.D., Nilsson, M.F., Kratz, G., Weber, G., Sørensen, O., Borregaard, N., et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120:3 (2003), 379–389.
79. Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., et al. Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127:3 (2007), 594–604.
80. Sforcin, J., Fernandes, A., Lopes, C., Bankova, V., Funari, S., Seasonal effect on Brazilian propolis antibacterial activity. J. Ethnopharmacol. 73:1 (2000), 243–249.
81. Ramos, A., Miranda, Jd., Propolis: a review of its anti-inflammatory and healing actions. J. Venom Anim. Toxins. 13:4 (2007), 697–710.
82. Cushnie, T.T., Lamb, A.J., Detection of galangin-induced cytoplasmic membrane damage in Staphylococcus aureus by measuring potassium loss. J. Ethnopharmacol. 101:1 (2005), 243–248.
83. Plaper, A., Golob, M., Hafner, I., Oblak, M., Šolmajer, T., Jerala, R., Characterization of quercetin binding site on DNA gyrase. Biochem. Biophys. Res. Commun. 306:2 (2003), 530–536.
84. Stepanović S., Antić N., Dakić I., Švabić-Vlahović M., In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs. Microbiol. Res. 158:4 (2003), 353–357.
85. Pippi, B., Lana, A., Moraes, R., Güez, C., Machado, M., Oliveira, L., et al. In vitro evaluation of the acquisition of resistance, antifungal activity and synergism of Brazilian red propolis with antifungal drugs on Candida spp. J. Appl. Microbiol. 118:4 (2015), 839–850.
86. Orsi, Rd.O., Fernandes, A., Bankova, V., Sforcin, J., The effects of Brazilian and Bulgarian propolis in vitro against Salmonella Typhi and their synergism with antibiotics acting on the ribosome. Nat. Prod. Res. 26:5 (2012), 430–437.
87. Takaisi-Kikuni, N.B., Schilcher, H., Electron microscopic and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenance. Planta Med. 60:03 (1994), 222–227.
88. Krol, W., Scheller, S., Shani, J., Pietsz, G., Czuba, Z., Synergistic effect of ethanolic extract of propolis and antibiotics on the growth of staphylococcus aureus. Arzneimittel-Forschung 43:5 (1993), 607–609.
89. Scheller, S., Dworniczak, S., Waldemar-Klimmek, K., Rajca, M., Tomczyk, A., Shani, J., Synergism between ethanolic extract of propolis (EEP) and anti-tuberculosis drugs on growth of mycobacteria. Z. Naturforsch. C 54:7–8 (1999), 549–553.
90. Onlen, Y., Tamer, C., Oksuz, H., Duran, N., Altug, M.E., Yakan, S., Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits. Microbiol. Res. 162:1 (2007), 62–68.
91. Onlen, Y., Duran, N., Atik, E., Savas, L., Altug, E., Yakan, S., et al. Antibacterial activity of propolis against MRSA and synergism with topical mupirocin. J. Altern. Complement. Med. 13:7 (2007), 713–718.
92. Bhaskar, S., Shalini, V., Helen, A., Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway. Immunobiology 216:3 (2011), 367–373.
93. Williams, R.J., Spencer, J.P., Rice-Evans, C., Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 36:7 (2004), 838–849.
94. Comalada, M., Camuesco, D., Sierra, S., Ballester, I., Xaus, J., Gálvez, J., et al. In vivo quercitrin anti‐inflammatory effect involves release of quercetin, which inhibits inflammation through down‐regulation of the NF-κB pathway. Eur. J. Immunol. 35:2 (2005), 584–592.
95. Youn, H.S., Lee, J.Y., Saitoh, S.I., Miyake, K., Kang, K.W., Choi, Y.J., et al. Suppression of MyD88-and TRIF-dependent signaling pathways of Toll-like receptor by (−)-epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem. Pharmacol. 72:7 (2006), 850–859.
96. Park, S.-J., Song, H.-Y., Youn, H.-S., Suppression of the TRIF-dependent signaling pathway of toll-like receptors by isoliquiritigenin in RAW264. 7 macrophages. Mol. Cells 28:4 (2009), 365–368.
97. Ahmed, E.T., Abo-Salem, O.M., Osman, A., The influence of Egyptian propolis on induced burn wound healing in diabetic rats; antibacterial mechanism. EWMA, 2012, 2011.
98. Henshaw, F.R., Bolton, T., Nube, V., Hood, A., Veldhoen, D., Pfrunder, L., et al. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study. J. Diabetes Complications 28:6 (2014), 850–857.
99. Parihar, A., Parihar, M.S., Milner, S., Bhat, S., Oxidative stress and anti-oxidative mobilization in burn injury. Burns 34:1 (2008), 6–17.
100. Olczyk, P., Ramos, P., Komosinska-Vassev, K., Stojko, J., Pilawa, B., Positive effect of propolis on free radicals in burn wounds. Evid. Based Complement. Altern. Med., 2013, 2013.
101. Valente, M.J., Baltazar, A.F., Henrique, R., Estevinho, L., Carvalho, M., Biological activities of Portuguese propolis: protection against free radical-induced erythrocyte damage and inhibition of human renal cancer cell growth in vitro. Food Chem. Toxicol. 49:1 (2011), 86–92.
102. Mohammadzadeh, S., Sharriatpanahi, M., Hamedi, M., Amanzadeh, Y., Ebrahimi, S.E.S., Ostad, S.N., Antioxidant power of Iranian propolis extract. Food Chem. 103:3 (2007), 729–733.
103. Noli, C., Miolo, A., The mast cell in wound healing. Vet. Dermatol. 12:6 (2001), 303–313.
104. Abo-Salem, O.M., El-Edel, R.H., Harisa, G., El-Halawany, N., Ghonaim, M.M., Experimental diabetic nephropathy can be prevented by propolis: effect on metabolic disturbances and renal oxidative parameters. Pak. J. Pharm. Sci. 22:2 (2009), 205–210.
105. Wang, T., Chen, L., Wu, W., Long, Y., Wang, R., Potential cytoprotection: antioxidant defence by caffeic acid phenethyl ester against free radical-induced damage of lipids, DNA, and proteins. Can. J. Physiol. Pharmacol. 86:5 (2008), 279–287.
106. Barroso, P.R., Lopes-Rocha, R., Pereira, E.M.F., Marinho, S.A., de Miranda, J.L., Lima, N.L., et al. Effect of propolis on mast cells in wound healing. Inflammopharmacology 20:5 (2012), 289–294.
107. Ng, M.F., The role of mast cells in wound healing. Int. Wound J. 7:1 (2010), 55–61.
108. Weller, K., Foitzik, K., Paus, R., Syska, W., Maurer, M., Mast cells are required for normal healing of skin wounds in mice. FASEB J. 20:13 (2006), 2366–2368.
109. Yang, L., Witten, T.M., Pidaparti, R.M., A biomechanical model of wound contraction and scar formation. Theor. Biol. 332 (2013), 228–248.
110. Wulff, B.C., Parent, A.E., Meleski, M.A., DiPietro, L.A., Schrementi, M.E., Wilgus, T.A., Mast cells contribute to scar formation during fetal wound healing. J. Invest. Dermatol. 132:2 (2012), 458–465.
111. Schwartzfarb, E., Kirsner, R.S., Understanding scarring: scarless fetal wound healing as a model. J. Invest. Dermatol., 132(2), 2012, 260.
112. Shin, D., Minn, K.W., The effect of myofibroblast on contracture of hypertrophic scar. Plast. Reconstr. Surg. 113:2 (2004), 633–640.
113. Van De Water, L., Varney, S., Tomasek, J.J., Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: opportunities for new therapeutic intervention. Adv. Wound Care 2:4 (2013), 122–141.
114. Cho, M.S., Park, W.S., Jung, W.-K., Qian, Z.-j., Lee, D.-S., Choi, J.-S., et al. Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells. Pharm. Biol. 52:7 (2014), 926–932.
115. Chen, L., Schrementi, M.E., Ranzer, M.J., Wilgus, T.A., DiPietro, L.A., Blockade of mast cell activation reduces cutaneous scar formation. PLoS One, 9(1), 2014, e85226.
116. Nader, M.A., Caffeic acid phenethyl ester attenuates IgE-induced immediate allergic reaction. Inflammopharmacology 21:2 (2013), 169–176.
117. Nakamura, R., Nakamura, R., Watanabe, K., Oka, K., Ohta, S., Mishima, S., et al. Effects of propolis from different areas on mast cell degranulation and identification of the effective components in propolis. Int. Immunopharmacol. 10:9 (2010), 1107–1112.
118. Bae, Y., Lee, S., Kim, S.-H., Chrysin suppresses mast cell-mediated allergic inflammation: involvement of calcium, caspase-1 and nuclear factor-κB. Toxicol. Appl. Pharmacol. 254:1 (2011), 56–64.
119. Hansson, G.K., Robertson, A.-K.L., Söderberg-Nauclér, C., Inflammation and atherosclerosis. Annu. Rev. Pathol. Mech. Dis. 1 (2006), 297–329.
120. Araujo, M.A., Libério, S.A., Guerra, R.N., Ribeiro, M.N.S., Nascimento, F.R., Mechanisms of action underlying the anti-inflammatory and immunomodulatory effects of propolis: a brief review. Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 22:1 (2012), 208–219.
121. Albuquerque-Júnior, R.L.Cd., Barreto, A.L.S., Pires, J.A., Reis, F.P., Lima, S.O., Ribeiro, M.A.G., et al. Effect of bovine type-I collagen-based films containing red propolis on dermal wound healing in rodent model. Int. J. Morphol. 27:4 (2009), 1105–1110.
122. Wang, Z., Jiang, W., Zhang, Z., Qian, M., Du, B., Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kappaB pathway in RAW 264.7 cells. J. Ethnopharmacol. 144:1 (2012), 145–150.
123. Farooqui, T., Farooqui, A.A., Molecular mechanism underlying the therapeutic activities of propolis: a critical review. Curr. Nutr. Food. Sci. 6:3 (2010), 186–199.
124. Song, Y.S., Park, E.-H., Hur, G.M., Ryu, Y.S., Lee, Y.S., Lee, J.Y., et al. Caffeic acid phenethyl ester inhibits nitric oxide synthase gene expression and enzyme activity. Cancer Lett. 175:1 (2002), 53–61.
125. Wang, K., Ping, S., Huang, S., Hu, L., Xuan, H., Zhang, C., et al. Molecular mechanisms underlying the in vitro anti-inflammatory effects of a flavonoid-rich ethanol extract from Chinese propolis (poplar type). Evid. Based Complement. Altern. Med., 2013, 2013.
126. Alp, H., Aytekin, I., Atakisi, O., Hatipoglu, N.K., Basara, K., Ogun, M., The effects of caffeic acid phenethyl ester and ellagic acid on the levels of malondialdehyde, reduced glutathione and nitric oxide in the lung, liver and kidney tissues in acute diazinon toxicity in rats. J. Anim. Vet. Adv. 10 (2011), 1488–1494.
127. Olczyk, P., Komosińska-Vassev, K., Winsz-Szczotka, K., Koźma, E.M., Wisowski, G., Stojko, J., et al. Propolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during experimental burn healing. J. Zhejiang Univ. Sci. B 13:11 (2012), 932–941.
128. Olczyk, P., Komosinska-Vassev, K., Wisowski, G., Mencner, L., Stojko, J., Kozma, E.M., Propolis modulates fibronectin expression in the matrix of thermal injury. Biomed. Res. Int., 2014, 2014.
129. Olczyk, P., Wisowski, G., Komosinska-Vassev, K., Stojko, J., Klimek, K., Olczyk, M., et al. Propolis modifies collagen types I and III accumulation in the matrix of burnt tissue. Evid. Based Complement. Altern. Med., 2013, 2013.
130. Abreu, A.M., Oliveira, D.W.D., Marinho, S.A., Lima, N.L., de Miranda, J.L., Verli, F.D., Effect of topical application of different substances on fibroplasia in cutaneous surgical wounds. ISRN Dermatol., 2012, 2012.
131. Iyyam Pillai, S., Palsamy, P., Subramanian, S., Kandaswamy, M., Wound healing properties of Indian propolis studied on excision wound-induced rats. Pharm. Biol. 48:11 (2010), 1198–1206.
132. Takzaree, N., Hadjiakhondi, A., Hassanzadeh, G., Rouini, M.R., Manayi, A., Synergistic effect of honey and propolis on cutaneous wound healing in rats. Acta Med. Iran. 54:4 (2016), 233–239.
133. Abu-Seida, A.M., Effect of propolis on experimental cutaneous wound healing in dogs. J. Vet. Intern. Med., 2015, 2015.
134. McLennan, S.V., Bonner, J., Milne, S., Lo, L., Charlton, A., Kurup, S., et al. The anti‐inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair. Regen. 16:5 (2008), 706–713.
135. Kucharzewski, M., Kózka, M., Urbanek, T., Topical treatment of nonhealing venous leg ulcer with propolis ointment. Evid. Based Complement. Altern. Med., 2013, 2013.
136. Kucharzewski, M., Kubacka, S., Urbanek, T., Wilemska-Kucharzewska, K., Morawiec, T., Stan Scheller: the forerunner of clinical studies on using propolis for poor and chronic nonhealing wounds. Evid. Based Complement. Altern. Med., 2013, 2013.
137. Huedo-Medina, T.B., Sánchez-Meca, J., Marín-Martínez, F., Botella, J., Assessing heterogeneity in meta-analysis: Q statistic or I² index?. Psychol. Methods, 11(2), 2006, 193.
138. Oryan, A., Moshiri, A., Tissue engineering: alternative option in managing large and massive tissue deficits. Trop. Med. Surg., 2013, 2013.
139. Oryan, A., Naeini, A.T., Nikahval, B., Gorjian, E., Effect of aqueous extract of Aloe vera on experimental cutaneous wound healing in rat. Vet. Arhiv. 80:4 (2010), 509–522.
140. Oryan, A., Zaker, S., Effects of topical application of honey on cutaneous wound healing in rabbits. Zentralbl. Veterinarmed. A 45:1–10 (1998), 181–188.
141. Broughton, G., Rohrich, R., Wounds and scars. SRPS 10:7 part I (2005), 5–7.
142. Rnjak, J., Wise, S.G., Mithieux, S.M., Weiss, A.S., Severe burn injuries and the role of elastin in the design of dermal substitutes. Tissue Eng. Part B Rev. 17:2 (2011), 81–91.
143. Hozzein, W.N., Badr, G., Al Ghamdi, A.A., Sayed, A., Al-Waili, N.S., Garraud, O., Topical application of propolis enhances cutaneous wound healing by promoting TGF-beta/Smad-mediated collagen production in a streptozotocin-induced type I diabetic mouse model. Cell. Physiol. Biochem. 37:3 (2015), 940–954.
144. Iacopino, A.M., Periodontitis and diabetes interrelationships: role of inflammation. Ann., Periodontol. 6:1 (2001), 125–137.
145. Phan, T., Lim, I., Sun, L., Chan, S., Bay, B., Tan, E., et al. Quercetin inhibits fibronectin production by keloid-derived fibroblasts. Implication for the treatment of excessive scars. J. Dermatol. Sci. 33:3 (2003), 192–194.
146. Morales, W., Garbbarino, J., Clinical Evaluation of a New Hypoallergic Formula of Propolis in Dressings, Bee Products: Properties, Application and Apitherapy. 1997, Plenum Press, New York.
147. Callejo, A., Armentia, A., Lombardero, M., Asensio, T., Propolis, a new bee‐related allergen. Allergy, 56(6), 2001, 579.
148. Silvani, S., Spettoli, E., Stacul, F., Tosti, A., Contact dermatitis in psoriasis due to propolis. Contact. Dermat. 37:1 (1997), 48–49.
149. Orsi, R., Sforcin, J., Funari, S., Gomes, J., Effect of propolis extract on guines pig lung mast cell. J. Venom. Anim. Toxins 11:1 (2005), 76–83.
150. Hausen, B., Wollenweber, E., Senff, H., Post, B., Propolis allergy.(II). The sensitizing properties of 1, 1-dimethylallyl caffeic acid ester. Contact. Dermat. 17:3 (1987), 171–177.
151. Hausen, B.M., Evaluation of the main contact allergens in propolis (1995 to 2005). Dermatitis 16:3 (2005), 127–129.
152. Kaneeda, J., Nishina, T., Safety of propolis: acute toxicity. Honney Bee Sci. 15 (1994), 29–33.
153. Gallo, E., Lucenteforte, E., Firenzuoli, F., Menniti-Ippolito, F., Maggini, V., Pugi, A., et al. Herbalists’ perception of risks involving commonly sold medicinal plants in Italy. Complement. Ther. Med. 22:1 (2014), 81–86.
154. Sforcin, J.M., V. Propolis: is there a potential for the development of new drugs?. J. Ethnopharmacol. 133:2 (2011), 253–260.